Medication oversupply in patients with diabetes

Research in Social and Administrative Pharmacy

Volumn 11, Issue 3, 2015, Pages 382-400

  Thorpe, Carolyn T ^a,b   Johnson, Heather ^c   Dopp, Anna Legreid ^d   Thorpe, Joshua M ^a,b   Ronk, Katie ^c   Everett, Christine M ^e   Palta, Mari ^c   Mott, David A ^f   Chewning, Betty ^f   Schleiden, Loren ^b   Smith, Maureen A ^c,f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d Pharmacy Society of Wisconsin   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Diabetes; Medication surplus; Oversupply; Refill adherence

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; PRESCRIPTION DRUG;

AGE; AGED; COHORT ANALYSIS; DIABETES MELLITUS; DRUG UTILIZATION; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICARE; MEDICATION COMPLIANCE; MIDDLE AGED; PRESCRIPTION; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UNITED STATES; WISCONSIN;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES; WISCONSIN;

EID: 84927961946     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2014.09.002     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011 2011, US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta (GA).
2. Grant R.W., Devita N.G., Singer D.E., Meigs J.B. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care May 1, 2003, 26:1408-1412.
3. American Diabetes Association Standards of medical care in diabetes - 2007. Diabetes Care Jan 2007, 30:S4-S41.
4. National Cholesterol Education Program Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
5. Odegard P.S., Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007, 33:1014-1029. discussion 1030-1011.
6. Chrischilles E., Rubenstein L., Van Gilder R., Voelker M., Wright K., Wallace R. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc 2007, 55:29-34.
7. Huang E.S. Appropriate application of evidence to the care of elderly patients with diabetes. Curr Diabetes Rev 2007, 3:260-263.
8. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003, 51:S265-S280. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders With Diabetes.
9. Cramer J.A. A systematic review of adherence with medications for diabetes. Diabetes Care 2004, 27:2285.
10. Bosworth H.B. Medication treatment adherence. Patient Treatment Adherence: Concepts, Interventions, and Measurement 2006, 147-194. Lawrence Erlbaum Associates, Mahwah, NJ. H.B. Bosworth, E.Z. Oddone, M. Weinberger (Eds.).
11. Gray S.L., Mahoney J.E., Blough D.K. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 2001, 35:539-545.
12. Balkrishnan R., Rajagopalan R., Camacho F.T., Huston S.A., Murray F.T., Anderson R.T. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003, 25:2958-2971.
13. Pladevall M., Williams L.K., Potts L., Divine G., Xi H., Lafata J.E. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004, 27:2800-2805.
14. Stroupe K.T., Teal E.Y., Tu W., Weiner M., Murray M.D. Association of refill adherence and health care use among adults with hypertension in an urban health care system. Pharmacotherapy 2006, 26:779-789.
15. Stroupe K.T., Teal E.Y., Weiner M., Gradus-Pizlo I., Brater D.C., Murray M.D. Health care and medication costs and use among older adults with heart failure. Am J Med 2004, 116:443-450.
16. Stroupe K.T., Murray M.D., Stump T.E., Callahan C.M. Association between medication supplies and healthcare costs in older adults from an urban healthcare system. J Am Geriatr Soc 2000, 48:760-768.
17. Krigsman K., Melander A., Carlsten A., Ekedahl A., Nilsson J.L. Refill non-adherence to repeat prescriptions leads to treatment gaps or to high extra costs. Pharm World Sci 2007, 29:19-24.
18. Evans J.M., Donnan P.T., Morris A.D. Adherence to oral hypoglycaemic agents prior to insulin therapy in Type 2 diabetes. Diabet Med 2002, 19:685-688.
19. Morningstar B.A., Sketris I.S., Kephart G.C., Sclar D.A. Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, Canada. J Clin Pharm Ther 2002, 27:213-220.
20. Spoelstra J.A., Stolk R.P., Heerdink E.R., et al. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?. Pharmacoepidemiol Drug Saf 2003, 12:121-127.
21. Andersson K., Melander A., Svensson C., Lind O., Nilsson J.L.G. Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur J Public Health 2005, 15:621-626.
22. Thorpe C.T., Bryson C.L., Maciejewski M.L., Bosworth H.B. Medication acquisition and self-reported adherence in veterans with hypertension. Med Care 2009, 47:474-481.
23. Steiner J.F., Prochazka A.V. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997, 50:105-116.
24. Hebert P.L., Geiss L.S., Tierney E.F., Engelgau M.M., Yawn B.P., McBean A.M. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999, 14:270-277.
25. Pham H.H., Schrag D., O'Malley A.S., Wu B.N., Bach P.B. Care patterns in Medicare and their implications for pay for performance. N Engl J Med 2007, 356:1130-1139.
26. Kautter J., Pope G.C., Trisolini M., Grund S. Medicare Physician Group Practice demonstration design: quality and efficiency pay-for-performance. Health Care Financ Rev 2007, 29:15-29.
27. Thorpe C.T., Flood G.E., Kraft S.A., Everett C.M., Smith M.A. Effect of patient selection method on provider group performance estimates. Med Care 2011, 49:780-785.
28. WCHQ Ambulatory Measure Specification: Postpartum Care Performance Measures 2009, Wisconsin Collaborative for Healthcare Quality.
29. Bryson C.L., Au D.H., Young B., McDonell M.B., Fihn S.D. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care 2007, 45:497-504.
30. Choudhry N.K., Shrank W.H., Levin R.L., et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009, 15:457-464.
31. Andersen R.M. Revisiting the behavioral model and access to medical care: does it matter?. J Health Soc Behav 1995, 36:1-10.
32. Blalock S.J. The theoretical basis for practice-relevant medication use research: patient-centered/behavioral theories. Res Soc Adm Pharm 2011, 7:317-329.
33. Bosworth H.B., Olsen M.K., Oddone E.Z. Improving blood pressure control by tailored feedback to patients and clinicians. Am Heart J 2005, 149:795-803.
34. Murray M.D., Morrow D.G., Weiner M., et al. A conceptual framework to study medication adherence in older adults. Am J Geriatr Pharmacother 2004, 2:36-43.
35. Ejlertsson G., Berg S. Continuity-of-care measures. An analytic and empirical comparison. Med Care 1984, 22:231-239.
36. Chronic Conditions Data Warehouse User Manual 2010, Buccaneer Computer Systems & Service, Inc, Buccaneer Computer Systems & Service, Inc., Warrenton, VA.
37. Elixhauser A., Steiner C., Harris D.R., Coffey R.M. Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27.
38. Standards of medical care in diabetes - 2010. Diabetes Care 2010, 33:S11-S61.
39. Yang M., Barner J.C., Worchel J. Factors related to antipsychotic oversupply among Central Texas Veterans. Clin Ther 2007, 29:1214-1225.
40. Rogers W.H. SG17: regression standard errors in clustered samples. Stata Tech Bull 1993, 13:19-23.
41. Campione J.R., Sleath B., Biddle A.K., Weinberger M. The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study. Am J Geriatr Pharmacother 2005, 3:229-239.
42. Farley J.F., Wang C.C., Hansen R.A., Voils C.I., Maciejewski M.L. Continuity of antipsychotic medication management for Medicaid patients with schizophrenia. Psychiatr Serv 2011, 62:747-752.
43. Martin B.C., Wiley-Exley E.K., Richards S., Domino M.E., Carey T.S., Sleath B.L. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009, 43:36-44.
44. Taitel M., Fensterheim L., Kirkham H., Sekula R., Duncan I. Medication days' supply, adherence, wastage, and cost among chronic patients in Medicaid. Medicare Medicaid Res Rev 2012, 2:E1-E13.
45. Domino M.E., Martin B.C., Wiley-Exley E., et al. Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment. Health Serv Res 2011, 46:900-919.